User menu

Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin

Bibliographic reference Delzenne, Nathalie M. ; Taper, Henryk ; Roberfroid, Marcel. Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin. In: Archives of Toxicology, Vol. 68, no. 6, p. 394-397 (1994)
Permanent URL http://hdl.handle.net/2078.1/12006
  1. Björkhem Ingemar, Danielsson Henry, Hydroxylations in biosynthesis and metabolism of bile acids, 10.1007/bf01770289
  2. Delzenne N, Taper H, Roberfroid M (1992a) Deoxycholic acid, but not lithocholic acid, modulates rat liver carcinogenesis. Cancer J 5 [2]: 107–110
  3. Delzenne N.M., Calderon P.Buc, Taper H.S., Roberfroid M.B., Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies, 10.1016/0378-4274(92)90156-e
  4. Greim Helmut, Czygan Peter, Schaffner Fenton, Popper Hans, Determination of bile acids in needle biopsies of human liver, 10.1016/0006-2944(73)90032-x
  5. Krisans S, Thompson S, Pena L, Kok E, Javitt N (1985) Bile acid synthesis in rat liver peroxisomes: metabolism of 26-hydroxycholesterol to 3β-hydroxy-5-cholenoic acid. J Lipid Res 26: 1324–1332
  6. Levine WG (1974) Effect of the hypolipidemic drug nafenopin (2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl) phenoxy) propionic acid; TPIA; Su-13,437), on the hepatic disposition of foreign compounds in the rat. Drug Metab Dispos 2: 178–186
  7. Maruyama Hiroshi, Tanaka Takuji, Williams Gary M., Effects of the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate on Enzymes in Rat Liver and on Carcinogen-Induced Liver Altered Foci in Comparison to the Promoter Phenobarbital, 10.1177/019262339001800204
  8. Neptun D, Cattley R, Popp J (1988) Bile acid profiles and serum enzyme alterations in rats fed the hepatocarcinogenic peroxisome proliferator WY-14,643. Clin Chem 34: 1196
  9. Numoto Satoshi, Mori Hideki, Furuya Keizo, Levine Walter G., Williams Gary M., Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide, 10.1016/0041-008x(85)90269-8
  10. Préat Véronique, Gerlache Jacques de, Lans Marc, Taper Henrik, Roberfroid Marcel, Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis, 10.1093/carcin/7.6.1025
  11. Redinger Richard N., Small Donald M., Primate Biliary Physiology VIII. THE EFFECT OF PHENOBARBITAL UPON BILE SALT SYNTHESIS AND POOL SIZE, BILIARY LIPID SECRETION, AND BILE COMPOSITION, 10.1172/jci107160
  12. Roberfroid M B, Delzenne N, Preat V, Modulation of Hepatocarcinogenesis, 10.1146/annurev.pa.31.040191.001115
  13. Shefer S, Hauser S, Mosbach E (1972) Stimulation of cholesterol 7-hydroxylase by phenobarbital in two strains of rats. J Lipid Res 13: 69–73
  14. Solt DB, Farber E (1976) New principle for the analysis of chemical carcinogenesis. Nature 263: 702–703
  15. Takita Minoru, Ikawa Shiro, Ogura Yoshio, Effect of Bile Duct Ligation on Bile Acid and Cholesterol Metabolism in Rats, 10.1093/oxfordjournals.jbchem.a122346
  16. Willson Richard A., Liem Hang H., Miyai Katsumi, Muller-Eberhard Ursula, Initial rate of sodium taurocholate uptake in isolated elutriated hepatocytes from untreated and phenobarbital-treated rats, 10.1016/0006-2952(85)90281-3